TuesdaySep 27, 2016 1:07 pm

Monaker Group, Inc. (MKGI) Gains Traction in Hot Niche of Travel Industry

Monaker Group, Inc. (OTCQB: MKGI), developer of a one-of-a-kind booking engine for lodging options, is quickly gaining ground in the lucrative travel industry. Among many other advantages, the company’s flagship NextTrip.com brand is the first and only real-time booking engine that features alternative lodging, as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. According to a draft prospectus filed with the SEC (http://nnw.fm/rz3mV), Monaker has initiated the process seeking to uplist shares of its common stock to the NYSE Market, an achievement that will enable the company to take its share in a…

Continue Reading

TuesdaySep 27, 2016 1:05 pm

Net Element, Inc. (NETE) Subsidiary Tapped as Payments Partner of Dunkin’ Donuts in Russia

Payment technology solutions provider Net Element (NASDAQ: NETE) this morning announced that its wholly owned PayOnline subsidiary has signed an agreement with Dunkin' Donuts (NASDAQ: DNKN) through which it will enable payment acceptance for online ordering and delivery services in Russia for one of the world's largest coffee and baked goods chains. Under the agreement, PayOnline will help the brand better serve its growing customer base in the Russian Federation by enabling easy and secure payment acceptance for online ordering and delivery services. To view the full press release, visit: http://nnw.fm/MCU9w About Net Element Net Element, Inc. (NASDAQ: NETE) operates…

Continue Reading

TuesdaySep 27, 2016 1:02 pm

Cyber Apps World (CYAP) Releases Savinst eCommerce App

Cyber Apps World (OTC: CYAP), a company focused on licensing of a worldwide e-commerce Internet platform, announces the availability of the Savinst e-Commerce App, which can now be viewed for iOS at the App Store and can be experienced at www.savinst.com. Savinst is a combination discount coupon and e-commerce platform. The company anticipates launch of the marketing process to engage retailers and local businesses to add products and service offering consumers deep discounts in excess of 25% within the next two months. To view the full press release, visit: http://nnw.fm/02nyB About Cyber Apps World Cyber Apps World is dedicated to…

Continue Reading

TuesdaySep 27, 2016 12:59 pm

PURE Bioscience, Inc. (PURE) Disinfectant Implemented in Chipotle’s Food Safety Program

As part of its “Our Food Safety Advancements” initiative, Chipotle Mexican Grill, Inc. (NYSE: CMG) has adopted PURE Bioscience’s (OTCQB: PURE) PURE® Hard Surface disinfectant as a food safety solution to eliminate and prevent Norovirus and other viruses and bacteria in all of the restaurant chain’s 2,100+ locations nationwide. PURE is the creator of the patented silver dihydrogen citrate (SDC) antimicrobial. Speaking of the use of the product in Chipotle stores, PURE CEO Hank R. Lambert in a news release stated, “We are proud that PURE Hard Surface disinfectant is playing an important role in Chipotle’s state of the art…

Continue Reading

TuesdaySep 27, 2016 12:38 pm

Inventergy Global, Inc. (INVT) Partner Engages Fortune 100 Company to Create Proof of Concept

Inventergy Global (NASDAQ: INVT), an intellectual property licensing company, reports that Pabellon, Inc., partner of INVT subsidiary Inventergy Innovations, LLC, is collaborating with a Fortune 100 company to create a proof of concept (POC) to demonstrate the ability of its Surface Plane Magnetic Technology™ capable of continuously charge remote Internet devices. The technology works by using Pabellon’s miniaturized, patented receivers to extract power, which is then delivered to remote sensing devices. Return path data is extracted from these devices to create "smart" sensing environments for various applications. To view the full press release, visit: http://nnw.fm/1YpIw About Inventergy Global, Inc. Inventergy…

Continue Reading

MondaySep 26, 2016 1:36 pm

Agora Holdings, Inc. (AGHI) Provides Update on FRAME Availability, Ongoing and Future Initiatives

Agora Holdings (OTC: AGHI) this morning issued a corporate update on the recent launch of its FRAME social media management application, as well as provided information on future developments and additional ongoing projects. Notably, Agora announced the availability of FRAME to the general public, available for download at Frame.ms and on the Android app marketplace, Google Play. Agora expects to release FRAME for iOS devices sometime next week. "Thus far, 2016 has been a year of exponential growth and realization of core technologies. With FRAME now available on the market, we will continue to develop the application, as well as…

Continue Reading

MondaySep 26, 2016 11:03 am

Actua Corp. (ACTA) Reaches Agreement to Sell GovDelivery for $153 Million in Cash

Actua Corp. (NASDAQ: ACTA) signed a definitive agreement to sell GovDelivery to an investor group led by Vista Equity Partners for $153 million in cash, subject to certain adjustments, including working capital, cash, debt and other items. The transaction is subject to customary closing conditions and is expected to close in the fourth quarter of 2016. Actua’s stated intentions are to use the proceeds to enhance shareholder value while staying focused on building its cloud businesses and repurchasing shares. To view the full press release, visit: http://nnw.fm/6Ecan About Actua Corp. Actua is a multi-vertical cloud company bringing the power of…

Continue Reading

MondaySep 26, 2016 10:56 am

Summit Therapeutics plc (SMMT) Receives Fast Track Designation for Duchenne Muscular Dystrophy

Summit Therapeutics plc (NASDAQ: SMMT) was pleased to announce today that the US Food and Drug Administration (‘FDA’) granted Fast Track designation for ezutromid in the treatment of Duchenne Muscular Dystrophy (DMD). Ezutromid is a utrophin modulator and represents a potential disease modifying treatment for all patients with the fatal muscle wasting disease DMD. Advantages of this designation include opportunities for frequent interactions with the FDA during all aspects of development, submission of a New Drug Application (‘NDA’) on a rolling basis, and eligibility for accelerated approval and priority review. To view the full press release, visit: http://nnw.fm/t43jX About Summit…

Continue Reading

MondaySep 26, 2016 10:56 am

Lipocine, Inc. (LPCN) Announces Phase 2b Study Results for LPCN 1111

Lipocine, Inc. (NASDAQ: LPCN) reported positive top-line results from a Phase 2b clinical study its novel oral testosterone replacement therapy ("TRT") product candidate. Named LPCN 1111, this prodrug is believed to have met the primary objectives of demonstrating the Phase 3 Dose as well as safety and tolerability of LPCN 1111 and its metabolites following oral administration of single and multiple doses in hypogonadal males. Notably, the prodrug was well tolerated with no drug-related severe or serious adverse events reported. To view the full press release, visit: http://nnw.fm/xY8YL About Lipocine Lipocine is a specialty pharmaceutical company focused on developing innovative…

Continue Reading

MondaySep 26, 2016 10:56 am

Array BioPharma, Inc. (ARRY) Reports Top-Line Results from Phase 3 Study

Array BioPharma, Inc. (NASDAQ: ARRY) jointly announced with Pierre Fabre the results from Part 1 of the Phase 3 COLUMBUS (Combined LGX818 Used with MEK162 in BRAF Mutant Unresectable Skin Cancer) study evaluating LGX818 (encorafenib), a BRAF inhibitor, and MEK162 (binimetinib), a MEK inhibitor, in patients with BRAF-mutant advanced, unresectable or metastatic melanoma. The study met its primary endpoint, meaningfully improving progression free survival (PFS) compared with vemurafenib, a BRAF inhibitor, alone. To view the full press release, visit: http://nnw.fm/iV5kO About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small…

Continue Reading

Contact us: 212.418.1217